Clinical Trial

numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON® LDLp Test System

AXINON® LDLp Test System receives Medical Device Authority (MDA) in Malaysianumares Health appoints BioD Medica for local distribution MDA filing…

6 days ago

BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator

Takeda will join five existing leading pharma company partners supporting and funding promising drug development startups.BASEL, Switzerland, Dec. 16, 2025…

7 days ago

BaseLaunch Announces the Addition of Takeda as New Pharmaceutical Partner to its Biotech Venture Incubator

Takeda will join five existing leading pharma company partners supporting and funding promising drug development startups.BASEL, Switzerland, Dec. 16, 2025…

7 days ago

PhaseV Closes 2025 with Record Growth, Supporting Biopharma’s Shift from AI Pilots to Full-Scale Execution

Company Enters 2026 Positioned for Wide-Scale Deployment, Fueled by $50M Series A, 40+ Global Sponsors, and Measurable ROIBOSTON, Dec. 16,…

7 days ago

PhaseV Closes 2025 with Record Growth, Supporting Biopharma’s Shift from AI Pilots to Full-Scale Execution

Company Enters 2026 Positioned for Wide-Scale Deployment, Fueled by $50M Series A, 40+ Global Sponsors, and Measurable ROIBOSTON, Dec. 16,…

7 days ago

IDC MarketScape: ZS named a Leader in life sciences R&D AI in clinical trials

EVANSTON, Ill., Dec. 16, 2025 /PRNewswire/ -- ZS has been named a Leader in the inaugural IDC MarketScape: Worldwide Life…

7 days ago

IDC MarketScape: ZS named a Leader in life sciences R&D AI in clinical trials

EVANSTON, Ill., Dec. 16, 2025 /PRNewswire/ -- ZS has been named a Leader in the inaugural IDC MarketScape: Worldwide Life…

7 days ago

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

7 days ago

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

7 days ago

Clearmind Medicine Announces Successful Completion of Second Cohort Enrollment in Ongoing FDA-Approved Phase I/IIa Trial for CMND-100

Vancouver, Canada, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

7 days ago